A Cannabis-Oil Epilepsy Study Defined Tolerance by Dose or Seizure Changes

A study's definition of tolerance determines which patients are counted. In a prospective epilepsy cohort receiving CBD-enriched cannabis oil, tolerance meant a specified increase in dose or seizure frequency under defined treatment conditions. It was not a direct measurement of receptor adaptation.

The formulation contained both CBD and THC

Ninety-two patients with treatment-resistant epilepsy received a cannabis extract described as having a 20:1 CBD-to-THC ratio. Ages ranged from childhood to adulthood. Seizure frequency was reported by patients or parents at clinic visits.

Several denominators described different outcomes

The abstract reports that eighty-four patients entered the tolerance analysis and twenty-one met its definition. Other reported denominators concerned treatment discontinuation and adverse reactions. These populations should not be interchanged when calculating or describing a rate.

The definition combined two pathways

Tolerance could be recorded following a substantial dose increase prompted by declining efficacy, or a substantial increase in seizure frequency after sufficient treatment duration without changes in other antiseizure medications. Such criteria describe a clinically important pattern but do not independently isolate its biological cause.

The cohort was not a blinded randomized comparison of purified CBD against placebo. Disease fluctuation, treatment decisions and the mixed formulation complicate attribution. The study therefore raises a question about declining effectiveness during continued treatment rather than proving that CBD alone produced pharmacological tolerance in every counted patient. It also does not justify changing an individual's antiseizure medication without clinical management.

Related: interpreting cannabis tolerance claims.

Research cited

Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist? Brain & development (2021). doi:10.1016/j.braindev.2020.06.018. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us